Cargando…

Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study

Detalles Bibliográficos
Autores principales:	Gibbs, A, Markham, T, Walsh, C, Bresnihan, B, Veale, D, FitzGerald, O
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834067/ http://dx.doi.org/10.1186/ar1589

Ejemplares similares

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations
por: Kaiser, Christina, et al.
Publicado: (2011)

Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
por: Pennington, Stephen R., et al.
Publicado: (2021)

Remission in psoriatic arthritis: is it possible and how can it be predicted?
por: Saber, Tajvur P, et al.
Publicado: (2010)

Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
por: Fearon, U, et al.
Publicado: (2005)

Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy - a single centre, open-label study
por: Pontifex, Eliza K, et al.
Publicado: (2011)

Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret(®)) in systemic juvenile idiopathic arthritis
por: Livermore, P, et al.
Publicado: (2008)

Biomarkers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review
por: Magee, Conor, et al.
Publicado: (2021)

Th17 and Th22 cells in psoriatic arthritis and psoriasis
por: Benham, Helen, et al.
Publicado: (2013)

PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS
por: Wikén, M, et al.
Publicado: (2013)

Psoriatic arthritis: from pathogenesis to therapy
por: FitzGerald, Oliver, et al.
Publicado: (2009)

Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis
por: Minnock, Patricia, et al.
Publicado: (2015)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
por: Haroon, Muhammad, et al.
Publicado: (2018)

The many faces of psoriatic arthritis: their genetic determinism
por: Winchester, Robert, et al.
Publicado: (2020)

The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005)

Psoriatic arthritis synovial histopathology: commentary on the article by Kruithof and colleagues
por: FitzGerald, Oliver
Publicado: (2005)

Differential Expression of NK Receptors CD94 and NKG2A by T Cells in Rheumatoid Arthritis Patients in Remission Compared to Active Disease
por: Walsh, Ceara E., et al.
Publicado: (2011)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis
por: Armstrong, April W., et al.
Publicado: (2014)

TNF polymorphisms are associated with the development of joint erosions in psoriatic arthritis
por: Kane, D, et al.
Publicado: (2003)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: Chandran, Vinod
Publicado: (2010)

Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
por: FitzGerald, Oliver, et al.
Publicado: (2015)

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis
por: Mc Ardle, Angela, et al.
Publicado: (2015)

The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
por: Leinonen, Mika, et al.
Publicado: (2014)

Peripheral corticotropin releasing hormone signaling is mediated by Type 1alpha receptors in early human inflammatory arthritis
por: McEvoy, A, et al.
Publicado: (2001)

Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open-label study
por: Grayson, Peter C., et al.
Publicado: (2017)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
por: Puig, Lluís
Publicado: (2017)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017)

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris
por: Bowes, John, et al.
Publicado: (2011)

Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?
por: Bresnihan, Barry, et al.
Publicado: (2004)

Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue
por: O'Hara, Rosemary, et al.
Publicado: (2000)

Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
por: Moran, Ellen M, et al.
Publicado: (2009)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
por: Nash, Peter, et al.
Publicado: (2020)

Targeted Therapies in Psoriatic Arthritis—An Update
por: Sundanum, Sonia, et al.
Publicado: (2023)

Effect of the IL-1 Receptor Antagonist Kineret(®) on Disease Phenotype in mdx Mice
por: Benny Klimek, Margaret E., et al.
Publicado: (2016)

From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
por: Zabotti, Alen, et al.
Publicado: (2020)

Sleep disorders in patients with psoriatic arthritis and psoriasis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018)

Prevalence and severity of fatigue in psoriasis and psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2020)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j08ihu8hiiq9d2pjs9ksar5bcj